Ventricular Tachycardia: Clinical Trials

6 trials for Ventricular Tachycardia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 recruiting, 1 withdrawn. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 2, Unknown 2, Recruiting 1, Withdrawn 1
Phase 23Completed 2, Unknown 1

Follow Ventricular Tachycardia: new trials by email Literature Review of Ventricular Tachycardia trials Research Report on Ventricular Tachycardia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial
Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT) - Ventricular Tachycardia
Phase 1RecruitingUniversity of Zurich152022-07-012026-08-21
Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia
Percutaneous inferior cervical sympathetic block - Ventricular Tachycardia
Phase 1WithdrawnUniversity of Missouri-Columbia2022-07-012023-08-07
SBRT in Chagas Disease Ventricular Tachycardia
Stereotactic Body Radiation Therapy - Ventricular Tachycardia, Chagas Disease
Phase 1 / Phase 2UnknownUniversity of Sao Paulo General Hospital102021-07-142024-07-16
Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia
stereotactic body radiotherapy (SBRT) - Ventricular Tachycardia, Cardiomyopathy
Phase 1 / Phase 2CompletedWashington University School of Medicine192016-07-012024-08-21
Botulinum Toxin Injection to Prevent Ventricular Arrhythmias
Botulinum Toxin - Symptomatic Ventricular Asystolia, Ventricular Tachycardia
Phase 1UnknownMeshalkin Research Institute of Pathology of Circulation302013-06-012015-09-25
Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker
Omegaven, Isotonic saline - Ventricular Tachycardia, Sudden Cardiac Death
Phase 1 / Phase 2CompletedAalborg University Hospital82007-10-012015-04-16

Narrower conditions

Tachycardia, Ventricular (6)  ·  Arrhythmias, Cardiac (1)  ·  Cardiomyopathies (1)  ·  Chagas Disease (1)  ·  Death, Sudden, Cardiac (1)  ·  Ventricular Premature Complexes (1)

Broader conditions

Cardiac Conduction System Disease (6)  ·  Cardiovascular Diseases (6)  ·  Heart Diseases (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Tachycardia (6)  ·  Arrhythmias, Cardiac (5)  ·  Cardiac Complexes, Premature (1)  ·  Death (1)  ·  Death, Sudden (1)  ·  Euglenozoa Infections (1)  ·  Heart Arrest (1)  ·  Infections (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)

Interventions

Radiosurgery (2)  ·  Botulinum Toxins (1)  ·  Sodium Chloride (1)  ·  fish oil triglycerides (1)

Sponsors

Aalborg University Hospital (1)  ·  Meshalkin Research Institute of Pathology of Circulation (1)  ·  University of Missouri-Columbia (1)  ·  University of Sao Paulo General Hospital (1)  ·  University of Zurich (1)  ·  Washington University School of Medicine (1)

Countries

Brazil (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Russia (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Mauricio I Scanavacca, MD, PhD (1)  ·  Phillip Cuculich, MD (1)  ·  Trine Madsen, MD (1)

Results publications

PMID 30586734, PMID 37941012